LENZ LENZ Therapeutics, Inc.
Executive Summary
A clear bullish institutional cluster emerged in LENZ during Q3 2025: 8 buyers (net +$108.9M) vs 3 sellers (net -$5.8M). Aggressive doubling by Citadel (+4320%), Franklin Resources (+6756%), and BofA (+414%) signals conviction around LENZ's presbyopia-correcting eye-drop franchise ahead of potential catalyst events. The buying is dominated by active managers and quant funds — not passive rebalancing — amplifying signal quality.
Key Financial Metrics
Institutional Positions
Net institutional flow: $108.9M
▲ Buyers (8)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| T. Rowe Price | DOUBLED | +1581.7% | $12.0K | $11.0K |
| Invesco | ADD | +36.6% | $17.0M | $9.2M |
| Citadel | DOUBLED | +4319.9% | $18.6M | $18.3M |
| BofA | DOUBLED | +413.6% | $16.3M | $14.3M |
| Wellington Management Group | ADD | +76.1% | $2.9M | $1.8M |
| UBS | ADD | +36.3% | $56.0M | $30.1M |
| Franklin Resources | DOUBLED | +6756.1% | $27.3M | $27.1M |
| Nuveen | ADD | +60.2% | $13.3M | $8.1M |
▼ Sellers (3)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Morgan Stanley | TRIM | -49.4% | $17.2M | -$3.4M |
| Point72 | TRIM | -45% | $18.1M | -$2.3M |
| Ubs Am, A Distinct Business Un | TRIM | -53.5% | $737.0K | -$192.4K |
Actionable Insight
Traders should monitor for a potential near-term catalyst event or DTC filing that could explain the Q3 cluster — the conviction doubling by Citadel and Franklin suggests a material thesis catalyst in the 6-month window. The negative T+20 drift on prior neutral reports (-19.8% on 5/4, -11.7% on 4/28) warns that LENZ has been selling off into bad news, but this cluster represents fresh insider-adjacent accumulation. Watch for Phase 3 data, licensing, or partnership announcements.
Key Facts
- 8 institutional buyers across Q3 2025 added a net $108.9M in LENZ positions; 3 sellers reduced holdings by $5.8M
- Citadel DOUBLED its position +4320% (to 399.4K shares worth $18.6M), Franklin Resources DOUBLED +6756% (to 587.1K shares worth $27.3M)
- UBS added +$30.1M to become the largest disclosed holder at $56.0M (1.20M shares)
- Only 3 sellers, all TRIMs (no full exits): Morgan Stanley -$3.4M, Point72 -$2.3M, UBS AM -$192K
- Aggregate buyer holdings rose to $151.3M, dwarfing the $30.1M seller side
- The 13F disclosure lag (45 days post-quarter) means these positions may already be partially unwound — but the cluster emerged before recent stock weakness
Financial Impact
8 buyers deployed net $108.9M into LENZ in Q3 2025, representing roughly 53% of the current $206M market cap being accumulated by tracked institutions
Risk Factors
- 13F data is 45+ days stale — cluster may have been partially or fully reversed before disclosure
- Historical calibration shows 'filing_report' score-6 calls on LENZ had only 34% observed P(up) at T+20 and a net negative mean alpha (-2.84% avg α after costs)
- Market cap of $206M makes LENZ a small-cap biotech subject to binary trial outcomes and liquidity gaps
- Previous longs (Feb '26 report's score-6 long call) produced -39.4% at T+20, indicating prior clusters may have been wrong
Market Snapshot
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-LENZ-2025-Q3 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 11, 2026
1d ago
|
Institutional Cluster
| $6.37 awaiting T+5 | awaiting T+5 | — | — |
|
Jun 7, 2026
5d ago
|
Press Release
| $7.01 awaiting T+5 | awaiting T+5 | — | — |
|
May 11, 2026
4w ago
|
8-K
| $7.91 $6.90 | ▼ −12.77% | ▼ −12.85% | — |
|
May 4, 2026
5w ago
|
Press Release
| $9.28 $9.99 | ▲ +7.65% | ▲ +4.71% | — |
|
Mar 24, 2026
11w ago
|
Press Release
| $9.03 $9.15 | ▲ +1.33% | ▲ +1.75% | — |
|
Feb 28, 2026
15w ago
|
Institutional Cluster
| $13.68 $12.30 | ▼ −10.09% | ▼ −8.88% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access